therapy of relapsed multiple myeloma - an update
Published 5 years ago • 1K plays • Length 49:25Download video MP4
Download video MP3
Similar videos
-
1:00:36
an update on new data of adcs for multiple myeloma
-
44:36
anti-bcma bispecific antibody for myeloma relapse after car t cells
-
1:33:39
the relevance of mrd assessment in the clinical management of multiple myeloma (mm) patients
-
1:02:56
managing toxicities in relapsed/refractory multiple myeloma: expert-led case discussions
-
1:12:04
multiple myeloma: a post-ash22 summary
-
56:37
management of multiple myeloma during covid 19
-
34:36
highlights from asco / eha 2021: latest updates on myeloma
-
37:42
ictc: session 1 - therapeutic landscape in the treatment of relapsed myeloma
-
21:22
multiple myeloma: combination therapy for relapsed/refractory patients
-
32:06
relapsed myeloma, treatment for relapsed myeloma, drugs in development, knowledge post-test
-
45:36
auto transplant vs chimeric antigen receptor t-cell therapy for relapsed dlbcl in partial remission
-
3:53
therapy for relapsed multiple myeloma
-
1:30
vcdi for multiple myeloma: an update
-
1:06:13
latest advances in multiple myeloma a post ash 2020 summary
-
45:36
autologous transplant vs chimeric antigen rec. t-cell therapy for relapsed dlbcl in partial rem.
-
42:38
idh inhibitors in relapsed/refractory aml
-
42:24
elranatamab in relapsed or refractory multiple myeloma: the magnetismm-1 phase 1 trial
-
24:43
multiple myeloma update: frontline therapy